Paroxysmal atrial fibrillation in elderly: linac-based sbrt arrhythmia radioablation phase 2 trial

被引：0
|
作者：
Gregucci, F. [1 ]
Di Monaco, A. [2 ]
Bonaparte, I. [1 ]
Surgo, A. [1 ]
Carbonara, R. [1 ]
Ciliberti, M. P. [1 ]
Di Guglielmo, F. [1 ]
Caliandro, M. [1 ]
Paulicelli, E. [1 ]
Ludovico, E. [3 ]
Romanazzi, I.
Grimaldi, M. [2 ]
Fiorentino, A. [1 ]
机构：
[1] Miulli Gen Reg Hosp, Radiat Oncol, Acquaviva Delle Fonti, Italy
[2] Miulli Gen Reg Hosp, Cardiol, Acquaviva Delle Fonti, Italy
[3] Miulli Gen Reg Hosp, Radiol, Acquaviva Delle Fonti, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1611
引用
收藏
页码：S1307 / S1307
页数：1
相关论文
共 50 条
  • [31] Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation A Prospective Randomized Trial
    Theis, Cathrin
    Konrad, Torsten
    Mollnau, Hanke
    Sonnenschein, Sebastian
    Kaempfner, Denise
    Potstawa, Maik
    Ocete, Blanca Quesada
    Bock, Karsten
    Himmrich, Ewald
    Muenzel, Thomas
    Rostock, Thomas
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2015, 8 (05): : 1080 - 1087
  • [32] Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation. ( vol 115 , pg 629 , 2024)
    Reddy, J.
    Lei, X.
    Bloom, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 119 (03): : 1034 - 1034
  • [33] Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial
    Holst, Anders G.
    Tomcsanyi, Janos
    Vestbjerg, Birgitte
    Grunnet, Morten
    Sorensen, Ulrik S.
    Diness, Jonas G.
    Bentzen, Bo H.
    Edvardsson, Nils
    Hohnloser, Stefan H.
    Bhatt, Deepak L.
    Dorian, Paul
    NATURE MEDICINE, 2024, 30 (01) : 106 - +
  • [34] Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial
    Anders G. Holst
    János Tomcsányi
    Birgitte Vestbjerg
    Morten Grunnet
    Ulrik S. Sørensen
    Jonas G. Diness
    Bo H. Bentzen
    Nils Edvardsson
    Stefan H. Hohnloser
    Deepak L. Bhatt
    Paul Dorian
    Nature Medicine, 2024, 30 : 106 - 111
  • [35] Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial
    Holst, Anders G.
    Tomcsanyi, Janos
    Vestbjerg, Birgitte
    Grunnet, Morten
    Sorensen, Ulrik S.
    Diness, Jonas G.
    Bentzen, Bo H.
    Edvardsson, Nils
    Hohnloser, Stefan H.
    Bhatt, Deepak L.
    Dorian, Paul
    NATURE MEDICINE, 2024, 30 (01) : 106 - +
  • [36] Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm INSTANT Phase 2 Trial
    Ruskin, Jeremy N.
    Camm, John
    Dufton, Christopher
    Woite-Silva, Anderson C.
    Tuininga, Ype
    Badings, Erik
    De Jong, Jonas S. S. G.
    Oosterhof, Thomas
    Aksoy, Ismail
    Kuijper, Aaf F. M.
    Van Gelder, Isabelle C.
    van Dijk, Vincent
    Nuyens, Dieter
    Schellings, Dirk
    Lee, Mark Young
    Kowey, Peter R.
    Crijns, Harry J. G. M.
    Maupas, Jean
    Belardinelli, Luiz
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (06) : 1021 - 1033
  • [37] Preliminary results of a phase 2 multicentre study of linac-based stereotactic radiotherapy boost for intermediate and high risk prostate cancer (PROMETHEUS)
    Pryor, David
    Sidhom, Mark
    Arumugam, Sankar
    Bucci, Joseph
    Gallagher, Sarah
    Smart, Joanne
    Grand, Mel
    Greer, Peter
    Keats, Sarah
    Wilton, Lee
    Martin, Jarad
    BJU INTERNATIONAL, 2018, 122 : 4 - 4
  • [38] Long term update on toxicity and survival of a phase II trial of linac-based stereotactic body radiation therapy for low-intermediate risk prostate cancer
    D'Agostino, Giuseppe R.
    Badalamenti, Marco
    Stefanini, Sara
    Baldaccini, Davide
    Franzese, Ciro
    Faro, Lorenzo Lo
    Di Cristina, Luciana
    Vernier, Veronica
    Reggiori, Giacomo
    Scorsetti, Marta
    PROSTATE, 2024, 84 (04): : 368 - 375
  • [39] Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: 'exposing the invisible'
    Okutucu, Sercan
    Katircioglu-Ozturk, Deniz
    Oto, Emre
    Guvenir, H. Altay
    Karaagaoglu, Ergun
    Oto, Ali
    Meinertz, Thomas
    Goette, Andreas
    EUROPACE, 2017, 19 (05): : 741 - 746
  • [40] Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2) A Randomized Trial
    Morillo, Carlos A.
    Verma, Atul
    Connolly, Stuart J.
    Kuck, Karl H.
    Nair, Girish M.
    Champagne, Jean
    Sterns, Laurence D.
    Beresh, Heather
    Healey, Jeffrey S.
    Natale, Andrea
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (07): : 692 - 699
12345